WorldPride rally in Washington, DC takes aim at Donald Trump's ‘deeply personal attacks' on LGBTQ+ community
LGBTQ+ people and their allies gathered yesterday at the Lincoln Memorial in Washington, DC – the site of Martin Luther King's 1963 'I Have a Dream' speech – to rally for preserving decades of progress while protesting setbacks under US president Donald Trump.
After the festive nature of a parade on Saturday through the streets of the capital, the rally, one of the main events of the weeks-long WorldPride celebration, turned more overtly political.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Journal
an hour ago
- The Journal
Wall Street Journal barred from covering Trump's Scotland visit after Epstein letter report
THE WALL STREET Journal, branded as a 'pile of garbage' by US President Donald Trump, has been evicted from the press pool that will be covering the president's weekend visit to Scotland, according to Politico . Politico reported that White House Press Secretary Karoline Leavitt confirmed to the outlet that the Wall Street Journal would not be included in the press pool for the Scotland trip due to its 'fake and defamatory conduct'. The Wall Street Journal's report on an alleged sexually suggestive letter reportedly sent by Trump to Epstein has exacerbated tensions between the president and one cohort of his supporters. A growing number of 'MAGA' supporters have grown frustrated over the failure and refusal to release the so-called 'Epstein files' and 'the list' said to contain the names of high-ranking politicians and famed public figures that sexually abused underage girls on the disgraced financier's infamous island. In the wake of the publication's article on the alleged letter, Trump announced that he would be pursuing legal action against the outlet. On Friday, he posted to Truth Social: 'We have just filed a POWERHOUSE Lawsuit against everyone involved in publishing the false, malicious, defamatory, FAKE NEWS 'article' in the useless 'rag' that is, The Wall Street Journal.' Advertisement He continued to say that his administration has 'proudly held to account' a list of media outlets, including 'The Fake Pulitzer Prizes'. 'This lawsuit is filed not only on behalf of your favorite President, ME, but also in order to continue standing up for ALL Americans who will no longer tolerate the abusive wrongdoings of the Fake News Media.' He had previously said that he told Rupert Murdoch, the owner, that it was a 'Scam' and that he shouldn't print the article. 'But he did, and now I'm going to sue his ass off, and that of his third rate newspaper.' The Wall Street Journal is not the first news organisation to have been blocked by Donald Trump. In February, he banned the Associated Press from the White House after it continued to use the term 'Gulf of Mexico' after Trump renamed it the 'Gulf of America'. Trump is to visit Turnberry and Aberdeen on his visit to Scotland. He is due to meet with UK Prime Minister Keir Starmer, as well as Scotland's First Minister John Swinney. He owns two golf courses in Scotland. Meanwhile, Police Scotland is reportedly being threatened with legal action by its own officers over the force's plans to police the US president's visit, with officers allegedly stating that excessive working hours breach its workforce agreement. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
RTÉ News
2 hours ago
- RTÉ News
US pulling out of UNESCO, state department confirms
The United States will leave the United Nations' culture and education agency UNESCO, the US state department has confirmed. The move is a blow to the Paris-based agency, founded after World War II to promote peace through international cooperation in education, science, and culture. President Donald Trump took similar steps during his first term, quitting the World Health Organization, the UN Human Rights Council, a global climate change accord and the Iran nuclear deal. Joe Biden reversed those decisions after taking office in 2021, returning the US to UNESCO, the WHO and the climate agreement. With Mr Trump now back in the White House, the US is once again pulling out of these global bodies. The administration has also ordered a 90-day pause on all US foreign assistance to assess alignment with Mr Trump's foreign policy priorities. UNESCO is best known for designating World Heritage Sites, including the Grand Canyon in the United States and the ancient city of Palmyra in Syria. The United States initially joined UNESCO at its founding in1945 but withdrew for the first time in 1984 in protest against alleged financial mismanagement and perceived anti-US bias, returning almost 20 years later in 2003 under President George W Bush, who then said the agency had undertaken needed reforms. UNESCO's full name is the United Nations Educational, Scientific and Cultural Organization. UNESCO officials said the agency was already a lot less dependent on the United States than in the past, but the move would nonetheless impact the agency, with some limited impact on programmes the US was financing. The United States provides about 8% of UNESCO's total budget, down from about 20% at the time Mr Trump first pulled the United States out of the agency.
RTÉ News
2 hours ago
- RTÉ News
AstraZeneca unveils $50 billion US investment as pharma tariff threat looms
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the US by 2030, it said, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy. The investment will fund a new drug manufacturing facility in Virginia and expand research and development (R&D) and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, it said in a statement. It will also upgrade the Anglo-Swedish drugmaker's US clinical trial supply network and support ongoing investment in novel medicines. AstraZeneca said the expansion supports its ambition to reach $80 billion in annual revenue by 2030, with half coming from the US. The US accounted for more than 40% of AstraZeneca's annual revenue in 2024, and the company had been prioritising the market - the world's largest, worth $635 billion - before Trump's return to office. The move to scale up its US footprint is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry and seeks to boost domestic manufacturing. The sector has historically been spared from trade disputes. Trump has called on pharma companies to make more of the medicines they sell in the US within the country, rather than importing active ingredients or finished medicines. He is also pushing for prices in the US to fall to what other countries pay. CEO Pascal Soriot announced the plans in Washington, saying he believes that drug prices need to rise elsewhere and "equalise" with other countries effectively contributing more to research and development costs. "The US cannot build or carry the cost of R&D for the entire world," he said. US Commerce Secretary Howard Lutnick's department is leading a probe into pharmaceutical imports that could pave the way for new tariffs. "For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness," said Lutnick in a statement issued by AstraZeneca. While Trump has repeatedly threatened tariffs on the sector, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any levies take effect. The company said that the timing and location of the announcement was linked to the US policy environment, though some of the spending would have occurred regardless so that the infrastructure for future medicines was in place. The pledge is in addition to the $3.5 billion in investments the company announced in November 2024, the statement said. The $50 billion pledge matches the commitment announced by Swiss rival Roche in April and follows new spending plans unveiled this year by Eli Lilly & Co, Johnson & Johnson, Novartis and Sanofi. Also present at the announcement was Virginia State Governor Glenn Youngkin, a vocal Trump ally who has defended the administration's tariff policies. The new Virginia facility - the company's largest single manufacturing investment - will produce active ingredients for AstraZeneca's experimental weight-loss medicines, including its oral GLP-1 candidate and an oral PCSK9 inhibitor for cholesterol management, it said. The company said the investment could create tens of thousands of new jobs, but declined to give specifics. It employs about 18,000 people in the US and has a global workforce of about 90,000. In January it scrapped plans to invest £450m in its vaccine manufacturing plant in northern England, citing a cut in government support. Earlier this month, The Times reported the company was considering moving its stock market listing from London, where it is the exchange's most valuable company worth 159 billion pounds, to the US. The company declined to comment.
